Oncologists' cost-effectiveness thresholds for new cancer therapies

被引：0
|
作者：
Nadler, E
Eckert, B
Neumann, P
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Harvard Univ, Boston, MA 02115 USA
来源：
VALUE IN HEALTH | 2005年 / 8卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)62576-4
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：239 / 239
页数：1
相关论文
共 50 条
  • [1] European perspective on the costs and cost-effectiveness of cancer therapies
    Drummond, Michael F.
    Mason, Anne R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (02) : 191 - 195
  • [2] Establishing cost-effectiveness of genetic targeting of cancer therapies
    Retel, Valesca P.
    Rutgers, E. J. Th
    Joore, M. A.
    van Harten, W. H.
    [J]. EJHP PRACTICE, 2008, 14 (06): : 52 - 54
  • [3] Cost-effectiveness of systemic therapies for metastatic pancreatic cancer
    Tam, V. C.
    Ko, Y. J.
    Mittmann, N.
    Cheung, M. C.
    Kumar, K.
    Hassan, S.
    Chan, K. K. W.
    [J]. CURRENT ONCOLOGY, 2013, 20 (02) : E90 - E106
  • [4] COST-EFFECTIVENESS OF NEW THERAPIES FOR MULTIPLE SCLEROSIS IN SPAIN
    Boix, B.
    Figueras, M.
    Riera, M.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A757 - A757
  • [5] Cost-effectiveness of biological therapies
    Feetham, Laura
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2019, 4 (05): : 337 - 337
  • [6] Cost-effectiveness of therapies for melanoma
    Johnston, Karissa M.
    McPherson, Emily
    Osenenko, Katherine
    Vergidis, Joanna
    Levy, Adrian R.
    Peacock, Stuart
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2015, 15 (02) : 229 - 242
  • [7] Cost-effectiveness of antiplatelet therapies
    Schleinitz, MD
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (09) : 1236 - 1236
  • [8] COST-EFFECTIVENESS OF MODERN THERAPIES
    Leighl, Natasha
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S88 - S88
  • [9] ASSESSING THE COST-EFFECTIVENESS OF THERAPIES IN THE THIRD QUADRANT ON THE COST-EFFECTIVENESS PLANE
    Nemeth, B.
    Eder, B.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A562 - A562
  • [10] Cost-effectiveness thresholds: a comment on the commentaries
    Culyer, Anthony J.
    [J]. HEALTH ECONOMICS POLICY AND LAW, 2016, 11 (04) : 445 - 447
12345